Short-term health-related quality of life, physical function and psychological consequences of severe COVID-19.
6-min walking test
COVID-19
Follow-up
Health Related Quality of Life
Post-Traumatic Stress Disorder
Journal
Annals of intensive care
ISSN: 2110-5820
Titre abrégé: Ann Intensive Care
Pays: Germany
ID NLM: 101562873
Informations de publication
Date de publication:
04 Jun 2021
04 Jun 2021
Historique:
received:
30
11
2020
accepted:
21
05
2021
entrez:
5
6
2021
pubmed:
6
6
2021
medline:
6
6
2021
Statut:
epublish
Résumé
Survivors of severe COVID-19 are at risk of impaired health-related quality of life (HRQoL) and persistent physical and psychological disability after ICU and hospital discharge. The subsequent social burden is a major concern. We aimed to assess the short-term HRQoL, physical function and prevalence of post-traumatic stress symptoms of invasively mechanically ventilated COVID-19 patients treated in our ICU. Prospective, observational cohort study in a follow-up clinic. Patients completed a 6-min walking test (6MWT) to assess their cardio-pulmonary function around 2 months (early follow-up) from hospital discharge, the EQ-5D-5L questionnaire for quality of life assessment around 2 months and at 6 months from hospital discharge and an anonymous web-based Impact of Event Scale-Revised (IES-R) questionnaire for Post-Traumatic Stress symptoms at 2 months. 47 patients attended our follow-up program, mean age 59 ± 10 years, median pre-morbid Clinical Frailty Scale (CFS) 2 [2-3]. The median distance walked in 6 min was 470 [406-516] m, 83 [67-99]% of the predicted value. Overall 1 out 3 patients and 4/18 (22%) among those with a good functional baseline prior to COVID-19 (CFS of 1 or 2) had lower (84%) than predicted 6MWT. EQ-5D-5L quality of life VAS was 80 [70-90] out of 100 at early follow-up with a slight improvement to 85 [77.5-90] at 6 months. Mobility, self-care and usual activities improved between the two timepoints, while pain/discomfort and depression/anxiety did not improve or got worse. The IES-R total score was greater than the threshold for concern of 1.6 in 27/41(66%) respondents. Patients recovering from severe COVID-19 requiring invasive mechanical ventilation surviving hospital discharge present with early mild to moderate functional impairment, mildly reduced quality of life from hospital discharge with an overall improvement of mobility, self-care and the ability of performing usual activities, while a worsening of pain and depression/anxiety symptoms at 6 months and a large proportion of symptoms of post-traumatic distress soon after hospital discharge.
Sections du résumé
BACKGROUND
BACKGROUND
Survivors of severe COVID-19 are at risk of impaired health-related quality of life (HRQoL) and persistent physical and psychological disability after ICU and hospital discharge. The subsequent social burden is a major concern. We aimed to assess the short-term HRQoL, physical function and prevalence of post-traumatic stress symptoms of invasively mechanically ventilated COVID-19 patients treated in our ICU.
METHODS
METHODS
Prospective, observational cohort study in a follow-up clinic. Patients completed a 6-min walking test (6MWT) to assess their cardio-pulmonary function around 2 months (early follow-up) from hospital discharge, the EQ-5D-5L questionnaire for quality of life assessment around 2 months and at 6 months from hospital discharge and an anonymous web-based Impact of Event Scale-Revised (IES-R) questionnaire for Post-Traumatic Stress symptoms at 2 months.
RESULTS
RESULTS
47 patients attended our follow-up program, mean age 59 ± 10 years, median pre-morbid Clinical Frailty Scale (CFS) 2 [2-3]. The median distance walked in 6 min was 470 [406-516] m, 83 [67-99]% of the predicted value. Overall 1 out 3 patients and 4/18 (22%) among those with a good functional baseline prior to COVID-19 (CFS of 1 or 2) had lower (84%) than predicted 6MWT. EQ-5D-5L quality of life VAS was 80 [70-90] out of 100 at early follow-up with a slight improvement to 85 [77.5-90] at 6 months. Mobility, self-care and usual activities improved between the two timepoints, while pain/discomfort and depression/anxiety did not improve or got worse. The IES-R total score was greater than the threshold for concern of 1.6 in 27/41(66%) respondents.
CONCLUSIONS
CONCLUSIONS
Patients recovering from severe COVID-19 requiring invasive mechanical ventilation surviving hospital discharge present with early mild to moderate functional impairment, mildly reduced quality of life from hospital discharge with an overall improvement of mobility, self-care and the ability of performing usual activities, while a worsening of pain and depression/anxiety symptoms at 6 months and a large proportion of symptoms of post-traumatic distress soon after hospital discharge.
Identifiants
pubmed: 34089104
doi: 10.1186/s13613-021-00881-x
pii: 10.1186/s13613-021-00881-x
pmc: PMC8177269
doi:
Types de publication
Journal Article
Langues
eng
Pagination
91Références
J Med Virol. 2021 Feb;93(2):1013-1022
pubmed: 32729939
CMAJ. 2005 Aug 30;173(5):489-95
pubmed: 16129869
JAMA. 2020 Aug 25;324(8):739-740
pubmed: 32777028
Am J Respir Crit Care Med. 2017 Nov 1;196(9):1122-1130
pubmed: 28537429
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
JAMA. 2020 Apr 28;323(16):1545-1546
pubmed: 32167538
Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1384-7
pubmed: 9817683
Eur Respir J. 2014 Dec;44(6):1428-46
pubmed: 25359355
Nat Rev Dis Primers. 2020 Jul 15;6(1):60
pubmed: 32669623
Lancet Respir Med. 2020 Aug;8(8):750-752
pubmed: 32422177
Eur Respir J. 2020 Oct 15;56(4):
pubmed: 32764112
Qual Life Res. 2013 Sep;22(7):1717-27
pubmed: 23184421
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
JAMA. 2020 Oct 6;324(13):1307-1316
pubmed: 32876695
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
Chest. 2013 Jul;144(1):24-31
pubmed: 23699588
Anaesthesia. 2020 Jul;75(7):928-934
pubmed: 32246838
N Engl J Med. 2011 Apr 7;364(14):1293-304
pubmed: 21470008
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Respir Med. 2020 Nov - Dec;174:106197
pubmed: 33120193
Am J Respir Crit Care Med. 2020 Mar 9;:
pubmed: 32150460
Eur Respir J. 2020 Nov 26;56(5):
pubmed: 33008936
Crit Care Med. 2016 May;44(5):954-65
pubmed: 26807686
Thorax. 2020 Dec 3;:
pubmed: 33273026
ERJ Open Res. 2020 Oct 26;6(4):
pubmed: 33257910
J Crit Care. 2020 Feb;55:171-176
pubmed: 31739086
Am J Respir Crit Care Med. 2006 Sep 1;174(5):538-44
pubmed: 16763220
BMC Neurol. 2011 Mar 24;11:37
pubmed: 21435231
J Intensive Care Med. 2021 Mar;36(3):343-351
pubmed: 31690160